{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:24:35Z","timestamp":1761744275467},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,9]]},"DOI":"10.18632\/oncotarget.6851","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T06:27:05Z","timestamp":1452320825000},"page":"6948-6959","source":"Crossref","is-referenced-by-count":18,"title":["IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms"],"prefix":"10.18632","volume":"7","author":[{"given":"Paula","family":"de Melo Campos","sequence":"first","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Machado-Neto","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Eide","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Howard Hughes Medical Institute, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha L.","family":"Savage","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Scopim-Ribeiro","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"},{"name":"Current address: Department of Internal Medicine, University of S\u00e3o Paulo at Ribeir\u00e3o Preto Medical School, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"da Silva Souza Duarte","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Favaro","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"},{"name":"Current address: Department of Biological Sciences, Federal University of S\u00e3o Paulo, Diadema, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lorand-Metze","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina E.","family":"Tognon","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Howard Hughes Medical Institute, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Druker","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Howard Hughes Medical Institute, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara T. Olalla","family":"Saad","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[{"name":"Hematology and Hemotherapy Center - University of Campinas\/Hemocentro - Unicamp, Instituto Nacional de Ci\u00eancia e Tecnologia do Sangue, Campinas, S\u00e3o Paulo, Brazil"},{"name":"Current address: Department of Internal Medicine, University of S\u00e3o Paulo at Ribeir\u00e3o Preto Medical School, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,9]]},"reference":[{"key":"1","first-page":"18","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"key":"2","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2008-03-077966","article-title":"Myeloproliferative disorders","volume":"112","author":"Gilliland","year":"2008","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Green","year":"2005","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2011-02-335042","article-title":"Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms","volume":"118","author":"Huntly","year":"2011","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cellsig.2011.01.009","article-title":"Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation","volume":"23","author":"Funakoshi-Tago","year":"2011","journal-title":"Cell Signal"},{"key":"6","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1073\/pnas.93.22.12490","article-title":"Cross-talk between the insulin and angiotensin signaling systems","volume":"93","author":"Kahn","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/dmrr.611","article-title":"The multi-faceted cross-talk between the insulin and angiotensin II signaling systems","volume":"22","author":"Saad","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"8","first-page":"151","article-title":"Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver","volume":"384","author":"Saad","year":"2003","journal-title":"Biol Chem"},{"key":"9","doi-asserted-by":"crossref","first-page":"24670","DOI":"10.1074\/jbc.270.42.24670","article-title":"4PS\/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice","volume":"270","author":"Kahn","year":"1995","journal-title":"J Biol Chem"},{"key":"10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bies.950190608","article-title":"The IRS-signalling system during insulin and cytokine action","volume":"19","author":"White","year":"1997","journal-title":"Bioessays"},{"key":"11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/cc.6.6.4035","article-title":"Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2","volume":"6","author":"Lee","year":"2007","journal-title":"Cell Cycle"},{"key":"12","doi-asserted-by":"crossref","first-page":"29415","DOI":"10.1074\/jbc.271.46.29415","article-title":"Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling","volume":"271","author":"Carter-Su","year":"1996","journal-title":"J Biol Chem"},{"key":"13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(17)42297-6","article-title":"The insulin signaling system","volume":"269","author":"Kahn","year":"1994","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"crossref","first-page":"26173","DOI":"10.1074\/jbc.272.42.26173","article-title":"Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation","volume":"272","author":"Mayeux","year":"1997","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"28527","DOI":"10.1074\/jbc.270.48.28527","article-title":"Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases","volume":"270","author":"O'Shea","year":"1995","journal-title":"J Biol Chem"},{"key":"16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4161\/cc.6.6.3987","article-title":"Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis","volume":"6","author":"Shaw","year":"2007","journal-title":"Cell Cycle"},{"key":"17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/377173a0","article-title":"Role of IRS-2 in insulin and cytokine signalling","volume":"377","author":"White","year":"1995","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.leu.2400927","article-title":"The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions--comparison to other cytokines and growth factors","volume":"12","author":"Ratajczak","year":"1998","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V94.11.3653","article-title":"The insulin-like growth factor system in normal and malignant hematopoietic cells","volume":"94","author":"Burdach","year":"1999","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1128\/MCB.24.22.9726-9735.2004","article-title":"Involvement of insulin receptor substrate 2 in mammary tumor metastasis","volume":"24","author":"Shaw","year":"2004","journal-title":"Mol Cell Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(02)03845-0","article-title":"BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells","volume":"535","author":"Saad","year":"2003","journal-title":"FEBS Lett"},{"key":"22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.leukres.2012.03.002","article-title":"Downregulation of IRS2 in myelodysplastic syndrome: a possible role in impaired hematopoietic cell differentiation","volume":"36","author":"Traina","year":"2012","journal-title":"Leuk Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1074\/jbc.M002633200","article-title":"Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes","volume":"276","author":"Kaushansky","year":"2001","journal-title":"J Biol Chem"},{"key":"24","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1182\/blood-2007-10-119743","article-title":"EPO receptor circuits for primary erythroblast survival","volume":"111","author":"Wojchowski","year":"2008","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Lopez","year":"2009","journal-title":"Blood"},{"key":"26","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1074\/jbc.273.25.15719","article-title":"Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase","volume":"273","author":"Kadowaki","year":"1998","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"crossref","first-page":"43684","DOI":"10.1074\/jbc.M408495200","article-title":"SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin","volume":"279","author":"Rui","year":"2004","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2005.07.004","article-title":"Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice","volume":"2","author":"Rui","year":"2005","journal-title":"Cell Metab"},{"key":"29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(99)01689-0","article-title":"Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1 rhabdomyosarcoma cells","volume":"464","author":"Muller","year":"1999","journal-title":"FEBS Lett"},{"key":"30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/leu.2014.156","article-title":"Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia","volume":"29","author":"White","year":"2015","journal-title":"Leukemia"},{"key":"31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a\u2212\/\u22125b\u2212\/\u2212 mice: a direct role for Stat5 in Bcl-X(L) induction","volume":"98","author":"Lodish","year":"1999","journal-title":"Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1111\/bph.12672","article-title":"JAK2\/STAT5\/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid beta-peptide Abeta25-35","volume":"171","author":"Li","year":"2014","journal-title":"Br J Pharmacol"},{"key":"33","doi-asserted-by":"crossref","first-page":"H476","DOI":"10.1152\/ajpheart.00079.2003","article-title":"STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning","volume":"285","author":"Das","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2006.08.007","article-title":"Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia","volume":"25","author":"Chen","year":"2007","journal-title":"Neurobiol Dis"},{"key":"35","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood-2009-10-248211","article-title":"High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia","volume":"117","author":"Sexl","year":"2011","journal-title":"Blood"},{"key":"36","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/ijc.29264","article-title":"Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis","volume":"136","author":"Rao","year":"2015","journal-title":"Int J Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Sexl","year":"2010","journal-title":"EMBO Mol Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/bjc.2014.349","article-title":"Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours","volume":"111","author":"Sebti","year":"2014","journal-title":"Br J Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","article-title":"Therapeutic destruction of insulin receptor substrates for cancer treatment","volume":"73","author":"Levitzki","year":"2013","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.bbamcr.2011.04.002","article-title":"Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt\/mTOR and MAPK pathways in K562 cells","volume":"1813","author":"Traina","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"41","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1535-7163.MCT-13-0842","article-title":"The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer","volume":"13","author":"Cox","year":"2014","journal-title":"Mol Cancer Ther"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:40:34Z","timestamp":1654065634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,9]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2,9]]}},"alternative-id":["6851","26755644"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6851","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,9]]}}}